MARKET

GCTK

GCTK

Glucotrack
NASDAQ
1.030
-0.080
-7.21%
Pre Market: 1.035 +0.005 +0.47% 07:39 10/12 EDT
OPEN
1.120
PREV CLOSE
1.110
HIGH
1.120
LOW
1.000
VOLUME
5.43K
TURNOVER
0
52 WEEK HIGH
136.29
52 WEEK LOW
1.000
MARKET CAP
1.05M
P/E (TTM)
-0.0057
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GCTK last week (0928-1002)?
Weekly Report · 10/05 09:32
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
Barchart · 10/01 16:15
Lokahi Therapeutics announces Qare platform
TipRanks · 09/30 13:20
Glucotrack’s Subsidiary Lōkahi Therapeutics Unveils Qare Comparative Health Platform For GLP-1 And Other Treatment Outcomes
Benzinga · 09/30 13:09
GlucoTrack Tightens Terms in Recent Financing Amendments
TipRanks · 09/28 21:47
Weekly Report: what happened at GCTK last week (0921-0925)?
Weekly Report · 09/28 09:30
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 09/25 17:05
Lokahi Therapeutics enters collaboration with Pepperdine E2B
TipRanks · 09/25 13:10
More
About GCTK
Glucotrack, Inc. is focused on the design, development, and commercialization of technologies for people with diabetes. The Company is engaged in developing a long-term Implantable Continuous Blood Glucose Monitor (CBGM) for people living with Type 1 diabetes and insulin-dependent Type 2 diabetes. Its CBGM is a long-term, implantable system that continually measures blood glucose levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration. Its CBGM technology allows for a less burdensome approach to glucose monitoring. It has also completed four animal studies with evolving prototype systems, all four of which consistently demonstrated a simple implant procedure, functionality, and safety. The Company has also demonstrated continuous glucose sensing in the epidural space via two additional animal trials, both of which demonstrated a simple implant procedure, functionality, and safety.

Webull offers GlucoTrack Inc stock information, including NASDAQ: GCTK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GCTK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GCTK stock methods without spending real money on the virtual paper trading platform.